ViVitro Labs appoints Douglas Bigrigg as North American Major Accounts Manager

September 22nd, 2015

Douglas Bigrigg

Douglas Bigrigg

VICTORIA, B.C., September 22, 2015— ViVitro Labs announces sales veteran, Douglas Bigrigg B. Eng., has joined the company as North American Major Accounts Manager. He is responsible for engaging with customers in North America including Heart Valve development, Heart Repair Device development and Heart Research organizations within Academia.

“Having worked with Douglas previously, I am confident that he will bring our major account clients and prospects a level of assistance and professionalism that reinforces the ViVitro reputation for quality and integrity.  His ability to understand the unique needs of clients and build deep relationships is a trademark that fits perfectly with our technical and service team,” notes ViVitro Labs GM, Gerry Wight.

Mr. Bigrigg brings over 20 years of sales experience to the position. Most recently he was President and Owner of Argosy Communication Products, a firm providing international sales representation and distribution for a variety of two-way radio manufacturers.

Douglas’ career includes extensive sales engineering experience in RF design and radio communications as well as product line management for oceanographic instrumentation. He enjoys the outdoors, hiking, fishing and hockey.

Douglas looks forward to meeting and helping North American clients and welcomes emails or phone calls.

About ViVitro Labs
ViVitro Labs Inc. offers industry-leading cardiovascular test equipment and related laboratory testing and consulting services. Hundreds of organizations in over 39 countries for 30 years have trusted ViVitro expertise, accuracy, and quality for their heart valve, LVAD, TAH, stent, and graft testing. ViVitro Laboratory Services holds ISO/IEC 17025 accreditation based on ISO 5840. ViVitro products are manufactured by StarFish Medical.

For more information please contact:

Mike Camplin
Director of Marketing
+1.250.388.3531 x210


    Join over 5000 cardiovascular device professionals who receive our testing and engineering insights and tips every month.